These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31169739)

  • 61. CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus-Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC).
    Trickey A; May MT; Schommers P; Tate J; Ingle SM; Guest JL; Gill MJ; Zangerle R; Saag M; Reiss P; Monforte AD; Johnson M; Lima VD; Sterling TR; Cavassini M; Wittkop L; Costagliola D; Sterne JAC;
    Clin Infect Dis; 2017 Sep; 65(6):959-966. PubMed ID: 28903507
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Impact of human immunodeficiency virus type 1 subtype on first-line antiretroviral therapy effectiveness.
    Bocket L; Cheret A; Deuffic-Burban S; Choisy P; Gerard Y; de la Tribonnière X; Viget N; Ajana F; Goffard A; Barin F; Mouton Y; Yazdanpanah Y
    Antivir Ther; 2005; 10(2):247-54. PubMed ID: 15865219
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Treatment outcomes among HIV-positive orphaned and non-orphaned children on antiretroviral therapy in Johannesburg, South Africa.
    Hendrickson C; Evans D; Brennan AT; Patz S; Untiedt S; Bassett J; Levin L; Sanne I; Fox MP
    S Afr Med J; 2019 Aug; 109(9):679-685. PubMed ID: 31635594
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Higher Risk of Mortality and Virologic Failure in HIV-Infected Patients With High Viral Load at Antiretroviral Therapy Initiation: An Observational Cohort Study in Chongqing, China.
    Zhou C; Zhang W; Lu R; Ouyang L; Xing H; Shao Y; Wu G; Ruan Y
    Front Public Health; 2022; 10():800839. PubMed ID: 35186841
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all?
    Migrant Health Working Group for the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord
    HIV Med; 2018 Jan; 19(1):42-48. PubMed ID: 28741837
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Inequalities in HIV disease management and progression in migrants from Latin America and sub-Saharan Africa living in Spain.
    Monge S; Alejos B; Dronda F; Del Romero J; Iribarren JA; Pulido F; Rubio R; Miró JM; Gutierrez F; Del Amo J;
    HIV Med; 2013 May; 14(5):273-83. PubMed ID: 23171059
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Two-year outcome of first-line antiretroviral therapy among HIV-1 vertically-infected children in Hanoi, Vietnam.
    Pham HV; Ishizaki A; Nguyen LV; Phan CT; Phung TT; Takemoto K; Pham AN; Bi X; Khu DT; Ichimura H
    Int J STD AIDS; 2015 Oct; 26(11):821-30. PubMed ID: 25332224
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Time-varying age- and CD4-stratified rates of mortality and WHO stage 3 and stage 4 events in children, adolescents and youth 0 to 24 years living with perinatally acquired HIV, before and after antiretroviral therapy initiation in the paediatric IeDEA Global Cohort Consortium.
    Desmonde S; Neilan AM; Musick B; Patten G; Chokephaibulkit K; Edmonds A; Duda SN; Malateste K; Wools-Kaloustian K; Ciaranello AL; Davies MA; Leroy V;
    J Int AIDS Soc; 2020 Oct; 23(10):e25617. PubMed ID: 33034417
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Assessment of population-based HIV RNA levels in a rural east African setting using a fingerprick-based blood collection method.
    Jain V; Liegler T; Kabami J; Chamie G; Clark TD; Black D; Geng EH; Kwarisiima D; Wong JK; Abdel-Mohsen M; Sonawane N; Aweeka FT; Thirumurthy H; Petersen ML; Charlebois ED; Kamya MR; Havlir DV;
    Clin Infect Dis; 2013 Feb; 56(4):598-605. PubMed ID: 23243180
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Time to first viral load testing among pregnant women living with HIV initiated on option B+ at 5 government clinics in Kampala city, Uganda: Retrospective cohort study.
    Atuhaire P; Matovu F; Nakalega R; Kataike H; Nabwana M; Lukyamuzi Z; Guwattude D
    Int J Infect Dis; 2021 Mar; 104():526-531. PubMed ID: 33434664
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Virologic outcome among patients receiving antiretroviral therapy at five hospitals in Haiti.
    Jean Louis F; Buteau J; François K; Hulland E; Domerçant JW; Yang C; Boncy J; Burris R; Pelletier V; Wagar N; Deyde V; Lowrance DW; Charles M
    PLoS One; 2018; 13(1):e0192077. PubMed ID: 29381736
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Outcomes in HIV-infected adults with tuberculosis at clinics with and without co-located HIV clinics in Botswana.
    Schwartz AB; Tamuhla N; Steenhoff AP; Nkakana K; Letlhogile R; Chadborn TR; Kestler M; Zetola NM; Ravimohan S; Bisson GP
    Int J Tuberc Lung Dis; 2013 Oct; 17(10):1298-303. PubMed ID: 24025381
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Does gender or mode of HIV acquisition affect virological response to modern antiretroviral therapy (ART)?
    Saunders P; Goodman AL; Smith CJ; Marshall N; O'Connor JL; Lampe FC; Johnson MA
    HIV Med; 2016 Jan; 17(1):18-27. PubMed ID: 26140659
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Risk factors for delayed viral suppression on first-line antiretroviral therapy among persons living with HIV in Haiti, 2013-2017.
    Rich SN; Cook RL; Yaghjyan L; Francois K; Puttkammer N; Robin E; Bae J; Joseph N; Pessoa-Brandão L; Delcher C
    PLoS One; 2020; 15(10):e0240817. PubMed ID: 33119631
    [TBL] [Abstract][Full Text] [Related]  

  • 75. High rate of loss to follow-up and virological non-suppression in HIV-infected children on antiretroviral therapy highlights the need to improve quality of care in South Africa.
    van Liere GAFS; Lilian R; Dunlop J; Tait C; Rees K; Mabitsi M; Ranoto L; Struthers HE; McIntyre JA; Peters RPH
    Epidemiol Infect; 2021 Mar; 149():e88. PubMed ID: 33745490
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Treatment outcome of the implementation of HIV test and treat policy at The AIDs Support Organization (TASO) Tororo clinic, Eastern Uganda: A retrospective cohort study.
    Opito R; Mpagi J; Bwayo D; Okello F; Mugisha K; Napyo A
    PLoS One; 2020; 15(9):e0239087. PubMed ID: 32960927
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The Impact of COVID-19 on the HIV Cascade of Care in Botswana - An Interrupted Time Series.
    Sehurutshi A; Farooqui H; Chivese T
    AIDS Behav; 2024 Aug; 28(8):2630-2638. PubMed ID: 38856847
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Differences between migrants and Spanish-born population through the HIV care cascade, Catalonia: an analysis using multiple data sources.
    Reyes-Urueña J; Campbell C; Hernando C; Vives N; Folch C; Ferrer L; Fernández-López L; Esteve A; Casabona J
    Epidemiol Infect; 2017 Jun; 145(8):1670-1681. PubMed ID: 28270252
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Phylodynamic analysis of HIV sub-epidemics in Mochudi, Botswana.
    Novitsky V; Kühnert D; Moyo S; Widenfelt E; Okui L; Essex M
    Epidemics; 2015 Dec; 13():44-55. PubMed ID: 26616041
    [TBL] [Abstract][Full Text] [Related]  

  • 80. HIV Incidence in Botswana Rural Communities With High Antiretroviral Treatment Coverage: Results From the Botswana Combination Prevention Project, 2013-2017.
    Ussery F; Bachanas P; Alwano MG; Lebelonyane R; Block L; Wirth K; Ussery G; Sento B; Gaolathe T; Kadima E; Abrams W; Segolodi T; Hader S; Lockman S; Moore J
    J Acquir Immune Defic Syndr; 2022 Sep; 91(1):9-16. PubMed ID: 35537094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.